Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
1.0 EUR
156.91 M EUR
1.08 B EUR
156.31 M
About Bio-Techne Corp
Sector
Industry
CEO
Kim Kelderman
Website
Headquarters
Minneapolis
Founded
1976
FIGI
BBG000GN3CZ3
Bio-Techne Corp. is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. It operates through the Protein Sciences, and Diagnostics and Genomics segments. The Protein Sciences segment develops and manufactures purified proteins, and reagent solutions. The Diagnostics and Genomics segment develops and manufactures diagnostic products. The company was founded in 1976 and is headquartered in Minneapolis, MN.
Bio-Techne Corp Common Stock (TECH) | Chart & Forecast SummaryKey Indicators on Trade Set Up in General
1. Push Set Up
2. Range Set up
3. Break & Retest Set Up
Active Sessions on Relevant Range & Elemented Probabilities;
* Asian(Ranging) - London(Upwards) - NYC(Downwards)
* Weekend Crypto Session
# Trend | Time Frame Conductive | Weekly Time Frame
- General
Bio-Techne Corp WCA - Rectangle Company: Bio-Techne Corp
Ticker: TECH
Exchange: NASDAQ
Sector: Healthcare
Introduction:
Today, we are looking at Bio-Techne Corp (TECH) on the weekly chart. Bio-Techne is a prominent name in the Healthcare sector and is traded on the NASDAQ exchange. Currently, the stock exhibits a Rectangle pat
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where TE1 is featured.
Related stocks
Frequently Asked Questions
The current price of TE1 is 44.0 EUR — it has increased by 0.47% in the past 24 hours. Watch BIO-TECHNE CORP. DL-,01 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange BIO-TECHNE CORP. DL-,01 stocks are traded under the ticker TE1.
TE1 stock has fallen by −0.92% compared to the previous week, the month change is a −9.28% fall, over the last year BIO-TECHNE CORP. DL-,01 has showed a −38.46% decrease.
We've gathered analysts' opinions on BIO-TECHNE CORP. DL-,01 future price: according to them, TE1 price has a max estimate of 83.98 EUR and a min estimate of 45.09 EUR. Watch TE1 chart and read a more detailed BIO-TECHNE CORP. DL-,01 stock forecast: see what analysts think of BIO-TECHNE CORP. DL-,01 and suggest that you do with its stocks.
TE1 stock is 2.79% volatile and has beta coefficient of 0.81. Track BIO-TECHNE CORP. DL-,01 stock price on the chart and check out the list of the most volatile stocks — is BIO-TECHNE CORP. DL-,01 there?
Today BIO-TECHNE CORP. DL-,01 has the market capitalization of 6.81 B, it has decreased by −3.59% over the last week.
Yes, you can track BIO-TECHNE CORP. DL-,01 financials in yearly and quarterly reports right on TradingView.
BIO-TECHNE CORP. DL-,01 is going to release the next earnings report on Aug 12, 2025. Keep track of upcoming events with our Earnings Calendar.
TE1 earnings for the last quarter are 0.52 EUR per share, whereas the estimation was 0.47 EUR resulting in a 10.32% surprise. The estimated earnings for the next quarter are 0.46 EUR per share. See more details about BIO-TECHNE CORP. DL-,01 earnings.
BIO-TECHNE CORP. DL-,01 revenue for the last quarter amounts to 292.26 M EUR, despite the estimated figure of 293.20 M EUR. In the next quarter, revenue is expected to reach 282.76 M EUR.
TE1 net income for the last quarter is 20.88 M EUR, while the quarter before that showed 33.70 M EUR of net income which accounts for −38.04% change. Track more BIO-TECHNE CORP. DL-,01 financial stats to get the full picture.
Yes, TE1 dividends are paid quarterly. The last dividend per share was 0.08 EUR. As of today, Dividend Yield (TTM)% is 0.66%. Tracking BIO-TECHNE CORP. DL-,01 dividends might help you take more informed decisions.
BIO-TECHNE CORP. DL-,01 dividend yield was 0.45% in 2024, and payout ratio reached 30.61%. The year before the numbers were 0.39% and 18.16% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of May 8, 2025, the company has 3.1 K employees. See our rating of the largest employees — is BIO-TECHNE CORP. DL-,01 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BIO-TECHNE CORP. DL-,01 EBITDA is 308.53 M EUR, and current EBITDA margin is 31.47%. See more stats in BIO-TECHNE CORP. DL-,01 financial statements.
Like other stocks, TE1 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIO-TECHNE CORP. DL-,01 stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BIO-TECHNE CORP. DL-,01 technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BIO-TECHNE CORP. DL-,01 stock shows the sell signal. See more of BIO-TECHNE CORP. DL-,01 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.